Gene test could make TB prevention safer and more effective
NCT ID NCT05413551
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adjusting the dose of a tuberculosis (TB) prevention drug based on a person's genetic makeup could improve treatment. Researchers enrolled 78 people and used a quick genetic test to guide the dose of isoniazid. The goal was to see if this personalized approach leads to better drug levels in the body, potentially making TB prevention more effective and reducing side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISONIAZID ADVERSE REACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Federal University of Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new tests predict who will develop active TB?
- Could aspirin or ibuprofen help beat TB faster?
- TB drug liver risk under the microscope
- Health workers on doorsteps: a new push to stop TB in kids
- Breastfeeding women finally included in TB drug research
- New study aims to safely prevent TB in pregnant women with HIV